Evidence Hub

Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome

Yu Wang

2016

148 participants

Abstract

Objective

To evaluate the effect of metformin treatment on the thyroid hormone profile in patients with polycystic ovary syndrome (PCOS).

Methods

A total of 148 patients with PCOS was specifically selected for either being diagnosed of hypothyroidism or subclinically hypothyroid or euthyroid without levothyroxine treatment before the starting of metformin. The serum levels of thyroid stimulating hormone (TSH) and free thyroxine (FT4) were measured before and after a 6-month period of metformin therapy.

Results

Thyroid function parameters did not change after starting metformin therapy in euthyroid patients with PCOS. In the 9 hypothyroid patients and 38 subclinical hypothyroid patients with PCOS, the basal median serum levels of TSH (P 0.05).

Conclusions

Metformin treatment has no effect on thyroid hormone, but has a TSH-lowering effect in hypothyroid and subclinically hypothyroid patients with PCOS.

Key words:

Metformin/TU; Polycystic ovary syndrome/DT; Thyroid gland/DE

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free